CPhi Preview 2013: Cambridge Laboratories - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

CPhi Preview 2013: Cambridge Laboratories

Untitled Document

2013 CPhI Exhibitor Preview

Company: : Cambridge Major Laboratories, Inc. (CML)

Description: CML is a global leader in API development and manufacturing to the pharmaceutical and biotechnology industries. CML produces pharmaceutical intermediates and API’s from preclinical through commercial manufacture. Operating across three facilities in the U.S. and Europe, CML services include process chemistry, API manufacturing, analytical sciences, solid state chemistry and quality assurance.

Website: www.c-mlabs.com

Booth Number: 50C52


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here